Radiation Oncology Perspective on Treatment of Oligometastatic Disease
Jason Efstathiou, MD, DPhil, defines oligometastatic prostate cancer and the impact advanced PET/CT imaging has had on the identification of this disease state. He reviews the data deliberating on treatment tailored for these patients in both the primary high-risk and recurrent settings.
Read More